Moderna Inc (NQ: MRNA )
130.51 +1.99 (+1.55%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Press Releases about Moderna Inc
Moderna to Present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
January 04, 2022
CAMBRIDGE, MA / ACCESSWIRE/ January 4, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO Stéphane Bancel...
Moderna to Provide Business and Pipeline Updates at the 2022 J.P. Morgan Healthcare Conference
January 03, 2022
CAMBRIDGE, MA / ACCESSWIRE / January 3, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO Stéphane Bancel...
Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of Moderna’s COVID-19 Vaccine or Updated Booster Candidate in 2022
December 27, 2021
Agreement includes 15 million doses for delivery in the third quarter of 2022 and 5 million doses for delivery in the fourth quarter of 2022 CAMBRIDGE, MA / ACCESSWIRE / December 27, 2021 / Moderna,...
Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional Doses of Moderna's COVID-19 Booster Vaccine in 2022
December 27, 2021
Total of 27.5 million doses ordered by the Swiss Federal Government to date CAMBRIDGE, MA / ACCESSWIRE / December 27, 2021 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger...
Moderna Announces Preliminary Booster Data and Updates Strategy to Address Omicron Variant
December 20, 2021
Moderna and Australia Announce Collaboration to Bring mRNA Manufacturing to Australia
December 13, 2021
Biotech Sector’s Response to Omicron Panic Should be Swift and Effective
December 07, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC – December 7, 2021 – USA News Group – Despite a level of panic that JP Morgan has already downplayed in its 2022 forecasts, the...
Moderna to Present at Upcoming Investor Conferences in December 2021
November 22, 2021
Moderna Tops BioSpace’s 2022 Best Places to Work Ranking in Large Employer Category
November 17, 2021
Global COVID-19 Therapeutics Market Size Now Expected To Exceed $25 Billion In 2030
November 09, 2021
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines or therapies, which will result in the...
Moderna to Present at Upcoming Investor Conferences in November 2021
October 28, 2021
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following